Anesthetics Flashcards
Ester local anesthetics
cocaine, procaine, oxiprocaine, propoxicaine, chlorprocaine, benzocaine, tetracaine,piperocaine,butacaine,meprilcaine,izobucaine, monocaine
Amide local anesthetics
lidocaine, mepivacaine, bupivacaine, hostacaine, cincocaine, articaine, prilocaine, etidocaine, centabucaridine
Local anesthetics mechanism
drugs that produce a temporary loss of pain, local anesthetics block reversible CNS and PNS conduction in a circumscribed area of body; act locally after reach blood concentration @ admin site is decreased and psychodynamic effects also diminished, etc read.
Cocaine was the
first local anesthetic
Lidocaine
Lidocaine is the first amino amide-type local anesthetic and was first synthesized under the name Xylocaine, first marketed in 1948.
Procaine
ester of para-aminobenzoic acid (metabolized by plasma esterase’s); onset of 6-10 min, excreted in urine as unchanged 2%; CI in children under 7, shock, hypotension, hepatic/renal disorders; AE: low toxicity (2x less than lidocaine), high allergenic risk (needs to be tested on PT before use), potency low (4x less than lidocaine), anti arrhythmic, vasodilator (arteriolospasm), anti-aging and low anti spastic action
Mepivicaine
Mechanism of action
like Lidocaine amide, but without vasodilator properties.
Pharmacokinetics
somewhat longer (20%) duration of action than Lidocaine .
Contraindications
not used in obstetrics since “trapped” in neonatal circulation due to lower pH of neonatal blood and hence greater potential for toxicity.
Adverse effects
low toxicity;
low allergenic risk.
Bupivacaine
amide with 2x longer duration than Lidocaine, greater cardio toxicity than Lidocaine due to slow dissociation from cardiac sodium channels in diastole, high toxicity, produces large vasodilation (bleeding during surgery thar Epinephrine cannot solve).
Tetracaine
prolonged duration of action due to slow ester hydrolysis, CI not in peripheral nerve blocks due to prolonged duration of action and potential for toxicity, high toxicity, significantly more potent than procaine, spinal anesthesia 1%,2% Tetracaine sol.
Prilocaine
Biotransformed in liver, lungs, kidney to toluidine and capable of causing methemoglobinemia; CI:methemoglobinemia, anemia, pregnancy, AE: very low toxicity
Inhalation (gaseous) anesthetics
halothane, isoflurane, enflurane, sevoflurane, methoxiflurane, desflurane
Inhalational analgesic
nitrous oxide
IV agents - antianxiety - benzodiazepines
midazolam, diazepam
IV agents - sedative/hypnotics - barbiturates
sodium thiopental, thiamylal sodium
IV agents - anesthetic agents
propofol, etomidate
IV agents - neuroleptic agent
droperidol
IV agent - dissociative agent
ketamine
IV Agent. - narcotic analgesic
Fentanyl
Nitrous oxide
Nitrous oxide is a widely used inhalation anesthetic agent, a colourless, odourless and not inflammable gas
Pharmacokinetics
due to limited solubility in blood, nitrous oxide has rapid onset and offset of effects;
increased pressure in “closed” compartments:
Nitrous oxide diffuses over 30 times more rapidly than oxygen;
preferential transfer leads to increased volume or pressure in air-filled cavities (due to 2nd gas effect);
increases in volume of pneumothorax, tympanic membrane rupture and increased gastric volume/pressure have been reported.
Adverse effects
at doses used for sedation: relaxation, body warmth, auditory effects and euphoria;
at high doses: dysphoria, nausea and vomiting;
studies have demonstrated that women exposed chronically to high levels of nitrous oxide (due to lack of scavenging of expired gasses) have decreased fertility.
Therapeutic notes
weak anesthetic agent with a short induction and a duration of action for about 20–30 minutes;
analgesia occurs with inspired concentrations of 20% and is used clinically in concentrations up to 70%;
it is used most often in combination with either IV or inhalational anesthetic agents to reduce potential cardiovascular effect of anesthetic;
in high concentrations 80% or more produces anesthesia and severe hypoxia and its unsuitable for use as a sole anesthetic agent;
it is mixed with 20% oxygen (the mixture has little or no effect on the cardiovascular and respiratory system).
Nitrous oxide has no significant effects on the respiratory, hepatic, renal, autonomic nervous systems and does not usualy produce any clinically significant cardiovascular effects.
Halothane
Pharmacodynamic effects
cardiovascular effects of Halothane:
affects both, the heart and peripheral circulation in a concentration-dependent manner;
hypotension;
decreases contractility and cardiac output;
changes in cardiac rhythm and conduction can occur with administration of inhalational anesthetic agents;
depresses the pacemaker activity resulting in sinus bradycardia (increased vagal tone) and A-V nodal rhythm;
sensitizes the heart to catecholamines and can produce premature ventricular contractions;
respiratory effects of Halothane:
depressed respiration;
bronchodilatation;
CNS effects of Halothane:
vasodilation on central vessels with increased central blood flow and increased CSL pressure;
produce an irregularly descending depression of the central nervous system;
renal effects of Halothane:
decreased renal blood flow and decreased glomerular filtration;
hepatic effects of Halothane:
decreased liver function;
“Halothane hepatitis” appears in two to five days after administration; the patient becomes pyrexic and complains of nausea and vomiting; the incidence is 1 in 7000 patients; death occurs in half of these patients;
these effects don’t appear in children;
precautions should be used in patients with hepatic disease and those previously exposed to Halothane;
muscular effects of Halothane:
relaxation appears in children and the uterine muscles.
desflurane
DESFLURANE
Pharmacodynamic effects
cardiovascular effects of Desflurane:
rapid increases in anesthetic concentration produces apparent activation of the sympathetic nervous system resulting in increased heart rate and HBP and that limits some use of Desflurane;
respiratory effects of Desflurane:
increased incidence of airway irritation (laryngospasm, coughing etc.) when it is used as a single anesthetic agent, especially during induction;
recent studies have demonstrated that carbon monoxide forms from the reaction of Desflurane with the material which absorbs CO2 in the anesthetic circuit; the amount of carbon monoxide formed depends upon the temperature and moisture of the material; there have been reports of patients experiencing a significant increase in carboxyhemoglobin with Desflurane.
GI effects of Desflurane:
incidence of nausea and vomiting is quite variable from patient to patient, and depends to some extent on the length of anesthetic administration.
Therapeutic notes
it has low solubility in blood which results in rapid onset and recovery;
it is not indicated for the induction of anesthesia especially in pediatric patients and patients with heart dissease.
Enflurane
depressant effects on blood pressure and myocardial contractility, same effects as halftone on organ systems, most respiratory depressant at low anesthetic concentration, high clinical concentration with hypocapnia associated with development of grand Mal seizures in small percentage of patients, not used much anymore, less potent than halothane, maintenance of anesthesia in adult patients
Isoflurane
same effect as halothane on organ systems, less hepatotoxic than others, more potent than enflurane, rapid induction of anesthesia
Methoxiflurane
AE: hypotension, depressed cardiac function, hepatotoxicity, nephrotoxicity; long induction of anesthesia, analgesic effects a couple;e of hours, produces muscle relaxation (doesn’t affect uterus)